Francis Medical Marks First New York Use of Vanquish System
Lake Success, New York, August 5, 2026 Francis Medical has reached an important commercialization milestone for its Vanquish® Water...
Drug Discovery
Advertisement
FibroBiologics Secures European Patent for Cartilage Gene Therapy
Houston, Texas, August 5, 2026 FibroBiologics, Inc. has strengthened its global intellectual property portfolio after the European Patent Office...
NIH Expands Human Cancer Models for Precision Oncology
Bethesda, Maryland, August 5, 2026 The National Institutes of Health (NIH), through the National Cancer Institute (NCI) and its...
Lunai Bioworks Expands Parkinson’s AI Drug Discovery Alliance
Sacramento & San Diego, California, August 4, 2026 Lunai Bioworks Inc. has announced a definitive Master Collaboration Agreement with...
Dianthus Unveils DNTH312 Dual-Target Autoimmune Therapy
NEW YORK and WALTHAM, Mass., August 4, 2026 Dianthus Therapeutics, Inc. announced the launch of DNTH312, an internally developed...
Advertisements
Nurix and Sanofi Advance Oral STAT6 Degrader into Phase 1 Clinical Development
BRISBANE, Calif., August 4, 2026 Nurix Therapeutics, Inc. announced it has earned a $10 million development milestone payment after...
Apertura Reports Progress in AAV Gene Therapy for TSC1
SILVER SPRING, Md. and NEW YORK, July 30, 2026 The TSC Alliance and Apertura Gene Therapy have announced the...
Relation and GSK Expand $110M AI Drug Discovery Alliance
LONDON, July 30, 2026 Relation Therapeutics has announced an expanded strategic collaboration with GSK that will accelerate the use...
GSK Invests £400M in Cambridge R&D Innovation Centre
LONDON, July 30, 2026 GSK has announced plans to establish a new global flagship research and development (R&D) centre...
Eisai Grants CORE Exclusive Global Oncology Rights
BOSTON, Mass. and TOKYO, Japan, July 28, 2026 CORE Biomedicine has entered into an exclusive global licensing agreement with...
Advertisement
